SUBJECTS : Hepatocellular Carcinoma | Cancer | Liver Cancer | Hepatitis B Viru
LATEST MANUSCRIPTS IN Journal of Hepatocellular Carcinoma
- Yunfei Zhang, Ruofan Sheng, Chun Yang, Yongming Dai, Mengsu Zeng. The Feasibility of Using Tri-Exponential Intra-Voxel Incoherent Motion DWI for Identifying the Microvascular Invasion in Hepatocellular Carcinoma. Journal of hepatocellular carcinoma. 2023, 10: 1659-1671
Cited : 3Read More - Jincheng Xiao, Jing Wang, Chaoqun Zhou, Junpeng Luo. Development and Validation of a Propionate Metabolism-Related Gene Signature for Prognostic Prediction of Hepatocellular Carcinoma. Journal of hepatocellular carcinoma. 2023, 10: 1673-1687Cited : 1Read More
- Valentina Zanuso, Angelo Pirozzi, Rita Balsano, Tiziana Pressiani, Lorenza Rimassa. Safety and Efficacy of Atezolizumab and Bevacizumab Combination as a First Line Treatment of Advanced Hepatocellular Carcinoma. Journal of hepatocellular carcinoma. 2023, 10: 1689-1708Cited : 3Read More
- Bingran Yu, Ning Zhang, Yun Feng, Yongfa Zhang, Ti Zhang, Lu Wang. Hepatectomy After Conversion Therapy with Hepatic Arterial Infusion Chemotherapy, Tyrosine Kinase Inhibitors and Anti-PD-1 Antibodies for Initially Unresectable Hepatocellular Carcinoma. Journal of hepatocellular carcinoma. 2023, 10: 1709-1721Cited : 2Read More
- Jingxin Yan, Yonghao Wen, Manjun Deng, Bin Ye, Xinlian Liu, Lushun Zhang. Transarterial Chemoembolization Plus Sorafenib versus Transarterial Chemoembolization Alone for Advanced Hepatocellular Carcinoma: An Umbrella Review of Meta-Analyses and Systematic Reviews. Journal of hepatocellular carcinoma. 2023, 10: 1723-1733Cited : 2Read More
- Bingran Yu, Ning Zhang, Yun Feng, Yongfa Zhang, Ti Zhang, Lu Wang. Tyrosine Kinase Inhibitors Plus Anti-PD-1 Antibodies with Hepatic Arterial Infusion Chemotherapy or Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma. Journal of hepatocellular carcinoma. 2023, 10: 1735-1748Cited : 2Read More
- Shusheng Lin, Yi Cao, Ke Zhu, Caini Yang, Xiangping Zhu, Honghua Zhang, Rui Zhang. Identification of a Novel Prognostic Signature Based on N-Linked Glycosylation and Its Correlation with Immunotherapy Response in Hepatocellular Carcinoma. Journal of hepatocellular carcinoma. 2023, 10: 1749-1765Cited : 4Read More
- Renhou Zhi, Pengfei Hao, Weibin Li, Haoliang Zhao. Expression of CKS2 in Hepatocellular Carcinoma: Correlation with Survival Outcomes and Immune Microenvironment. Journal of hepatocellular carcinoma. 2023, 10: 1767-1784Cited : 3Read More
- Shanshan Chen, Youjia Duan, Yongchao Zhang, Long Cheng, Liang Cai, Xiaopu Hou, Wei Li. Associations Between Single Nucleotide Polymorphisms of Hypoxia-Related Genes and Capsule Formation in Hepatocellular Carcinoma. Journal of hepatocellular carcinoma. 2023, 10: 1785-1797Cited : 0Read More
- Shu-Qun Li, Jun-Yi Wu, Jia-Yi Wu, Huang Xie, Jin-Hai Li, Zhen-Xin Zeng, Yang-Kai Fu, De-Yi Liu, Han Li, Wei-Zhao Chen, Jing-Yao Huang, Mao-Lin Yan. Transarterial Chemoembolization Plus Lenvatinib and PD-1 Inhibitors for Hepatocellular Carcinoma with Main Trunk Portal Vein Tumor Thrombus: A Multicenter Retrospective Study. Journal of hepatocellular carcinoma. 2023, 10: 1799-1811Cited : 8Read More
- Qiumei Lin, Zongwei Jiang, Dan Mo, Fengfei Liu, Yuling Qin, Yihua Liang, Yuchen Cheng, Hao Huang, Min Fang. Beta2-Microglobulin as Predictive Biomarkers in the Prognosis of Hepatocellular Carcinoma and Development of a New Nomogram. Journal of hepatocellular carcinoma. 2023, 10: 1813-1825Cited : 1Read More
- Meng-Chao Luo, Jia-Yi Wu, Jun-Yi Wu, Zhong-Tai Lin, Yi-Nan Li, Zhen-Xin Zeng, Shao-Ming Wei, Mao-Lin Yan. Early Tumor Marker Response Predicts Treatment Outcomes in Patients with Unresectable Hepatocellular Carcinoma Receiving Combined Lenvatinib, Immune Checkpoint Inhibitors, and Transcatheter Arterial Chemoembolization Therapy. Journal of hepatocellular carcinoma. 2023, 10: 1827-1837Cited : 2Read More
- Jing Yang, Shuang Liang, Huahui Liu, Cai Hu, Sainan Guan, Haiyu Kang, Erjiao Xu, Ronghua Yan. Efficacy and Safety of Microwave Ablation Assisted by Ultrasound Fusion Imaging for Primary and Secondary Liver Cancers with a Diameter of 3-7 Cm. Journal of hepatocellular carcinoma. 2023, 10: 1839-1848Cited : 2Read More
- Teng Long, Zhoutian Yang, Huilan Zeng, Weijie Wu, Zhiwen Hu, Zhenyun Yang, Dandan Hu, Zhongguo Zhou, Minshan Chen, Yaojun Zhang. Comparable Clinical Outcomes Between Transarterial Chemoembolization or Hepatic Arterial Infusion Chemotherapy Combined with Tyrosine Kinase Inhibitors and PD-1 Inhibitors in Unresectable Hepatocellular Carcinoma. Journal of hepatocellular carcinoma. 2023, 10: 1849-1859Cited : 3Read More
- Qin Shi, Peng Huang, Zihan Zhang, Wen Zhang, Lingxiao Liu, Zhiping Yan. Hepatocellular Carcinoma with Radiological Progression: Lenvatinib Plus PD-1 Inhibitor Combined with Microwave Ablation and Synchronous Transarterial Chemoembolization. Journal of hepatocellular carcinoma. 2023, 10: 1861-1871Cited : 0Read More
